ATE483980T1 - Verfahren zur diagnose von schwangerschaftsstörungen - Google Patents

Verfahren zur diagnose von schwangerschaftsstörungen

Info

Publication number
ATE483980T1
ATE483980T1 AT03791161T AT03791161T ATE483980T1 AT E483980 T1 ATE483980 T1 AT E483980T1 AT 03791161 T AT03791161 T AT 03791161T AT 03791161 T AT03791161 T AT 03791161T AT E483980 T1 ATE483980 T1 AT E483980T1
Authority
AT
Austria
Prior art keywords
prostaglandins
suspension
woman
diagnosing pregnancy
pregnancy disorders
Prior art date
Application number
AT03791161T
Other languages
English (en)
Inventor
Hamutal Meiri
Original Assignee
Diagnostic Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Diagnostic Technologies Ltd filed Critical Diagnostic Technologies Ltd
Application granted granted Critical
Publication of ATE483980T1 publication Critical patent/ATE483980T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/471—Pregnancy proteins, e.g. placenta proteins, alpha-feto-protein, pregnancy specific beta glycoprotein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Reproductive Health (AREA)
  • Pregnancy & Childbirth (AREA)
  • Gynecology & Obstetrics (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT03791161T 2002-08-29 2003-08-28 Verfahren zur diagnose von schwangerschaftsstörungen ATE483980T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US40668702P 2002-08-29 2002-08-29
PCT/IL2003/000706 WO2004021012A2 (en) 2002-08-29 2003-08-28 Method of diagnosis of pregnancy-related complications

Publications (1)

Publication Number Publication Date
ATE483980T1 true ATE483980T1 (de) 2010-10-15

Family

ID=31978341

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03791161T ATE483980T1 (de) 2002-08-29 2003-08-28 Verfahren zur diagnose von schwangerschaftsstörungen

Country Status (7)

Country Link
US (2) US7488585B2 (de)
EP (1) EP1537420B1 (de)
AT (1) ATE483980T1 (de)
AU (1) AU2003256036B2 (de)
CA (1) CA2497071C (de)
DE (1) DE60334462D1 (de)
WO (1) WO2004021012A2 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE483980T1 (de) * 2002-08-29 2010-10-15 Diagnostic Technologies Ltd Verfahren zur diagnose von schwangerschaftsstörungen
WO2007086067A1 (en) * 2006-01-30 2007-08-02 Diagnostic Technologies Ltd. Method for monitoring tocolytic treatment
EP2038431A1 (de) * 2007-02-01 2009-03-25 Diagnostic Technologies Ltd. Verfahren zum bestimmen der präklampsie-gefahr
EP2912458B1 (de) 2012-10-24 2018-07-18 NYU Winthrop Hospital Nichtinvasiver biomarker zur identifizierung von patientinnen mit erhöhtem risiko für eine frühgeburt
KR20200109293A (ko) 2017-09-13 2020-09-22 프로제너티, 인크. 자간전증 바이오마커 및 관련된 시스템 및 방법
WO2021113710A1 (en) 2019-12-04 2021-06-10 Progenity, Inc. Assessment of preeclampsia using assays for free and dissociated placental growth factor
CN112341533A (zh) * 2020-11-20 2021-02-09 东北师范大学 无标签人半乳糖凝集素13及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3230996A1 (de) 1982-08-20 1984-02-23 Behringwerke Ag, 3550 Marburg Neues protein (pp(pfeil abwaerts)1(pfeil abwaerts)(pfeil abwaerts)3(pfeil abwaerts)), verfahren zu seiner anreicherung und gewinnung sowie seine verwendung
US5198366A (en) * 1986-03-23 1993-03-30 Technion Research & Development Foundation Ltd. Method for the detection of pregnancy disorders
ES2033834T3 (es) 1987-03-24 1993-04-01 Technion Research & Development Foundation Ltd. Un metodo para determinar alteraciones de la gestion.
US5849474A (en) 1995-12-06 1998-12-15 Olson; Camilla M. Diagnosis of preeclampsia in mammals
US5972594A (en) 1997-02-05 1999-10-26 University Of Pittsburgh Method for screening for reproductive tract inflammation and preeclampsia using neutrophil defensins
IL123098A0 (en) * 1998-01-29 1998-09-24 Diagnostic Technologies Ltd Placental protein 13
IL129273A (en) 1999-03-30 2003-10-31 Diagnostic Technologies Ltd Monoclonal antibody to placental protein 13 and immunoassay and kit using said antibody
ATE483980T1 (de) * 2002-08-29 2010-10-15 Diagnostic Technologies Ltd Verfahren zur diagnose von schwangerschaftsstörungen

Also Published As

Publication number Publication date
AU2003256036A1 (en) 2004-03-19
EP1537420B1 (de) 2010-10-06
CA2497071C (en) 2009-12-22
EP1537420A2 (de) 2005-06-08
US7488585B2 (en) 2009-02-10
US20060040337A1 (en) 2006-02-23
AU2003256036B2 (en) 2009-02-26
WO2004021012A3 (en) 2004-04-01
US20090227036A1 (en) 2009-09-10
DE60334462D1 (de) 2010-11-18
CA2497071A1 (en) 2004-03-11
WO2004021012A2 (en) 2004-03-11

Similar Documents

Publication Publication Date Title
ATE330226T1 (de) Pränatales screening für downs-syndrom
ATE338818T1 (de) Verfahren zur diagnose des glaukoms
ATE533857T1 (de) Zirkulierende mrna als diagnostische marker für erkankungen die mit einer schwangerschaft zusammenhängen
ATE509275T1 (de) Schnelltest für glykiertes albumin
ES2112833T3 (es) Aislamiento de celulas fetales a partir de sangre materna para permitir el diagnostico prenatal.
AR063820A2 (es) Anticuerpo purificado y kit para detectar la prenez en un animal bovino
WO2005111626A3 (en) Adam12, a novel marker for abnormal cell function
WO2005037059A3 (en) Multi-marker screening protocol for fetal abnormalities
DE60334462D1 (de) En
GB9113791D0 (en) Method for the immunological determination of the carboxyterminal propeptide of type i procollagen
UY28558A1 (es) Proteína
US20110223622A1 (en) Methods and Kits for Predicting the Onset of Labour
BR0313194A (pt) Método para diagnose de esclerose múltipla
CA2390881A1 (en) Method and system for real-time analysis and display of curve connection quality
DE69525400D1 (de) Vorgeburtliche Überprüfung von Schwangerschaftsabnormitäten
DE50211356D1 (de) Hybridverfahren zur herstellung von trägern für die analytbestimmung
CA2523690A1 (en) Use of protein masp as a marker for colorectal cancer
DE69418759D1 (de) Vorgeburtliche Überprüfung von Missbildungen der Chromosomen
NO20061758L (no) Hurtigtest for diagnose av Alzheimers sykdom
DE60203524D1 (de) Verfahren zur messung des arteriolendrucks
Wyndham Deaths from destructive lifestyles (largely preventable) among economically active Whites in South Africa, 1968-1977
KR970000247A (ko) 산전 자궁내 감염과 주산기 이환진단을 위한 진단시약 및 진단키트
Singh et al. Serum levels and urinary excretion of magnesium, calcium and electrolytes in mild pregnancy-induced hypertension
DE69721889D1 (de) Pränatales Testverfahren für Down-Syndrom
CN206876716U (zh) 一种免疫印迹法过敏原检测试剂盒

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties